PayerTalkCE

This podcast explores payer best practices in managing atopic dermatitis, emphasizing the role of type 2 inflammation and its impact on patient outcomes. Experts discuss current treatment guidelines, the efficacy of emerging therapies, and strategies for tailoring care to patient needs, including those with darker skin tones. Key barriers such as access to dermatologists, treatment complexity, and psychosocial impacts are highlighted, with insights on payer strategies to improve access and affordability. Topics include clinical guidelines, innovative payer programs, formulary management, and value-based contracting to enhance care quality while controlling costs.

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at https://www.impactedu.net/type2-inflammation-atopic-dermatitis-management.

This podcast provides an in-depth exploration of type 2 inflammation and its role in the pathophysiology and management of atopic dermatitis, tailored for health plan professionals. Experts discuss the molecular mechanisms driving the condition, including key cytokines like IL-4 and IL-13, and highlight the clinical and quality-of-life impacts for patients. The conversation covers the evolution of targeted therapies, including biologics and JAK inhibitors, and emphasizes the importance of shared decision-making and timely treatment. Special attention is given to addressing health disparities in diagnosing and treating patients with darker skin tones, underscoring the need for equitable care strategies.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/type2-inflammation-atopic-dermatitis-management.

This PayerTalkCE podcast, hosted by Dana McCormick and Dr. Jordan Graff, focuses on managing diabetic retinopathy (DR) and diabetic macular edema (DME) in underserved populations. Key challenges include limited access to care, transportation, and socioeconomic barriers. They highlight the importance of early intervention, remote screening technologies, and advancements in anti-VEGF therapies to reduce treatment burden and improve outcomes. Discussions emphasize balancing the cost of newer, more effective treatments with their ability to reduce the frequency of visits and improve patient adherence. Collaboration between payers and providers is critical to enhance access, manage costs, and optimize care for vulnerable populations.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/managing-dr-dme-ce/.

In this PayerTalkCE podcast, Dr. Gary Owens and Dr. Adrienne Scott discuss the care coordination challenges and treatment strategies for patients with age-related macular degeneration (AMD) and comorbid conditions like hypertension and diabetes. They emphasize the importance of individualized therapy, including treat-and-extend protocols and balancing treatment burden with efficacy. Key challenges include patient adherence, travel burden, and out-of-pocket costs. They explore payer roles in supporting patient care through formulary flexibility, feedback on prescribing patterns, and patient support services. The conversation highlights collaboration between payers and providers to optimize outcomes and cost-effectiveness for patients with AMD.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/amd-care-coordination-ce/.

In this discussion, Dana McCormick, RPh, introduces a CE program on managing eosinophilic esophagitis (EoE) with insights from Dr. Evan Dellon and Dr. Drake Reiter. Dr. Dellon highlights advancements in EoE treatment guidelines, including new pharmacologic options, and stresses individualized care strategies. Dr. Reiter emphasizes the value of clinical guidelines for payers in managing EoE, aligning formularies, and supporting optimal outcomes. They discuss barriers to EoE care, such as access to specialists, insurance coverage, and treatment costs. They also explore potential solutions like telehealth, patient education, and payer-supported multidisciplinary care models to improve accessibility and efficiency in EoE management.

This activity is certified for CME/CNE/CPE credit. To participate and earn

credit, visit us at

https://www.impactedu.net/type2-inflammation-eoe-management.

This podcast addresses the role of type 2 inflammation in the pathophysiology and management of eosinophilic esophagitis (EoE), with a focus on evolving treatment strategies. Dr. Evan Dellon discusses the mechanisms behind EoE, the limitations of current allergy testing, and the challenges in diagnosing the condition due to non-specific symptoms. He reviews current therapeutic approaches, including dietary modifications, proton pump inhibitors, topical steroids, and biologics like dupilumab, which target specific inflammatory pathways. Emerging therapies and combination treatments are also explored, highlighting opportunities for optimizing patient outcomes in this chronic condition.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/type2-inflammation-eoe-management.

This podcast focuses on improving equity in pediatric atopic dermatitis management, highlighting key challenges in access to care for children with moderate to severe cases. Dr. Joy Wan emphasizes the importance of timely referrals to dermatologists, noting the frustrations families face due to delays in treatment. She discusses the complexities of treatment, considering safety, efficacy, and the individual needs of children. The discussion also underscores the psychosocial impact of atopic dermatitis, including sleep disruption and mental health concerns. Payers are encouraged to adapt policies that consider these unique challenges to ensure appropriate access and support for families managing this chronic condition.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopic-dermatitis-pediatric-management.

The podcast features an expert panel discussing trends and opportunities for continuous glucose monitoring (CGM) in managing diabetes within managed care. Dr. Timothy Gilbert emphasizes technological advancements in CGM, illustrating benefits in improving glycemic control and reducing diabetes-related complications. The conversation highlights CGM's role in patient engagement by providing real-time data to manage diabetes effectively. Dr. Maureen Hennessey discusses the integration of CGM into quality measures like HEDIS, focusing on its potential to enhance diabetes care and address health disparities. Susan Wescott and Sean Chitwood elaborate on health plan best practices, financial benefits, and the impact of CGM on quality metrics.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at

https://www.managedcarecgm.com/diabetes-quality-and-cgm.

This PayerTalkCE episode provides an in-depth examination of the management and treatment of Multiple Sclerosis (MS) from both a clinical and payer perspective. Experts discuss various MS subtypes, emphasizing the importance of tailored treatments based on individual patient needs and disease progression. Key considerations include drug efficacy, side effects, comorbidities, and the economic aspects such as cost-effectiveness and payer coverage. The conversation highlights the challenges and strategies in optimizing treatment pathways, navigating benefit design complexities, and the potential of personalized medicine in improving patient outcomes. The discussion is highly relevant for health plan professionals, focusing on the integration of clinical insights with payer policies to enhance the management of MS.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at

https://www.impactedu.net/ms-current-strategies.

To participate in this on-demand continuing education activity and earn credit, visit us at https://www.impactedu.net/psoriasis-advancements/. In this episode of PayerTalkCE you will learn about:

Emerging and recently approved psoriasis therapies

Strategies to improve and expedite access to high quality care

Comorbidities, history, and patient preferences that influence therapeutic selection

This activity is certified for nurses, pharmacists, and physicians. Please review the front matter at https://www.impactedu.net/psoriasis-advancements/ for full accreditation information.